4//SEC Filing
Heyman Tomas J. 4
Accession 0000950170-23-029231
CIK 0001744659other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:54 PM ET
Size
8.4 KB
Accession
0000950170-23-029231
Insider Transaction Report
Form 4
Heyman Tomas J.
Director
Transactions
- Exercise/Conversion
Common Stock
2023-06-16$25.04/sh+26,000$651,040→ 26,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-06-16−26,000→ 0 totalExercise: $25.04Exp: 2030-06-09→ Common Stock (26,000 underlying) - Sale
Common Stock
2023-06-16$54.67/sh−26,000$1,421,529→ 0 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.52 to $54.89, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]The options are vested and currently exercisable.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001814673
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:54 PM ET
- Size
- 8.4 KB